C37H67NO14
Neat
749.94
Erythromycin F; 82230-93-1; Erythromycin, 16-hydroxy-; UNII-NM325T380N; NM325T380N; ERYTHROMYCIN IMPURITY A [EP IMPURITY]; ERYTHROMYCIN ESTOLATE IMPURITY A [EP IMPURITY]; ERYTHROMYCIN STEARATE IMPURITY A [EP IMPURITY]; ERYTHROMYCIN ETHYLSUCCINATE IMPURITY A [EP IMPURITY]; ERYTHROMYCIN LACTOBIONATE IMPURITY A [EP IMPURITY]; ERYTHROMYCIN IMPURITY A (EP IMPURITY); ERYTHROMYCIN ESTOLATE IMPURITY A (EP IMPURITY); ERYTHROMYCIN STEARATE IMPURITY A (EP IMPURITY); ERYTHROMYCIN ETHYLSUCCINATE IMPURITY A (EP IMPURITY); ERYTHROMYCIN LACTOBIONATE IMPURITY A (EP IMPURITY); RefChem:137789; (3R, 4S, 5S, 6S, 7S, 9S, 11R, 12R, 13S, 14R)-6-(4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy-14-ethyl-7, 12, 13-trihydroxy-4-((2R, 4R, 5R, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyloxan-2-yl)oxy-3-(hydroxymethyl)-5, 7, 9, 11, 13-pentamethyl-oxacyclotetradecane-2, 10-dione; (3R, 4S, 5S, 6S, 7S, 9S, 11R, 12R, 13S, 14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7, 12, 13-trihydroxy-4-[(2R, 4R, 5R, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyloxan-2-yl]oxy-3-(hydroxymethyl)-5, 7, 9, 11, 13-pentamethyl-oxacyclotetradecane-2 and 10-dione; DZCOSWPAQGXWKC-OGLSFEOFSA-N; Erythromycin EP Impurity A
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-[(2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7, 12, 13-trihydroxy-4-[(2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyloxan-2-yl]oxy-3-(hydroxymethyl)-5, 7, 9, 11, 13-pentamethyl-oxacyclotetradecane-2 and 10-dione
InChI=1S/C37H67NO14/c1-13-25-37(9,46)30(42)20(4)27(40)18(2)15-35(7,45)32(52-34-28(41)24(38(10)11)14-19(3)48-34)21(5)29(23(17-39)33(44)50-25)51-26-16-36(8,47-12)31(43)22(6)49-26/h18-26,28-32,34,39,41-43,45-46H,13-17H2,1-12H3/t18-,19-,20+,21+,22+,23-,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1